{"title":"Cardiac Repair and Regeneration via Advanced Technology: Narrative Literature Review.","authors":"Yugyung Lee, Sushil Shelke, Chi Lee","doi":"10.2196/65366","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases (CVDs) are the leading cause of death globally, and almost one-half of all adults in the United States have at least one form of heart disease. This review focused on advanced technologies, genetic variables in CVD, and biomaterials used for organ-independent cardiovascular repair systems.</p><p><strong>Objective: </strong>A variety of implantable and wearable devices, including biosensor-equipped cardiovascular stents and biocompatible cardiac patches, have been developed and evaluated. The incorporation of those strategies will hold a bright future in the management of CVD in advanced clinical practice.</p><p><strong>Methods: </strong>This study employed widely used academic search systems, such as Google Scholar, PubMed, and Web of Science. Recent progress in diagnostic and treatment methods against CVD, as described in the content, are extensively examined. The innovative bioengineering, gene delivery, cell biology, and artificial intelligence-based technologies that will continuously revolutionize biomedical devices for cardiovascular repair and regeneration are also discussed. The novel, balanced, contemporary, query-based method adapted in this manuscript defined the extent to which an updated literature review could efficiently provide research on the evidence-based, comprehensive applicability of cardiovascular devices for clinical treatment against CVD.</p><p><strong>Results: </strong>Advanced technologies along with artificial intelligence-based telehealth will be essential to create efficient implantable biomedical devices, including cardiovascular stents. The proper statistical approaches along with results from clinical studies including model-based risk probability prediction from genetic and physiological variables are integral for monitoring and treatment of CVD risk.</p><p><strong>Conclusions: </strong>To overcome the current obstacles in cardiac repair and regeneration and achieve successful therapeutic applications, future interdisciplinary collaborative work is essential. Novel cardiovascular devices and their targeted treatments will accomplish enhanced health care delivery and improved therapeutic efficacy against CVD. As the review articles contain comprehensive sources for state-of-the-art evidence for clinicians, these high-quality reviews will serve as a first outline of the updated progress on cardiovascular devices before undertaking clinical studies.</p>","PeriodicalId":87288,"journal":{"name":"JMIR biomedical engineering","volume":"10 ","pages":"e65366"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11956377/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMIR biomedical engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2196/65366","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Cardiovascular diseases (CVDs) are the leading cause of death globally, and almost one-half of all adults in the United States have at least one form of heart disease. This review focused on advanced technologies, genetic variables in CVD, and biomaterials used for organ-independent cardiovascular repair systems.
Objective: A variety of implantable and wearable devices, including biosensor-equipped cardiovascular stents and biocompatible cardiac patches, have been developed and evaluated. The incorporation of those strategies will hold a bright future in the management of CVD in advanced clinical practice.
Methods: This study employed widely used academic search systems, such as Google Scholar, PubMed, and Web of Science. Recent progress in diagnostic and treatment methods against CVD, as described in the content, are extensively examined. The innovative bioengineering, gene delivery, cell biology, and artificial intelligence-based technologies that will continuously revolutionize biomedical devices for cardiovascular repair and regeneration are also discussed. The novel, balanced, contemporary, query-based method adapted in this manuscript defined the extent to which an updated literature review could efficiently provide research on the evidence-based, comprehensive applicability of cardiovascular devices for clinical treatment against CVD.
Results: Advanced technologies along with artificial intelligence-based telehealth will be essential to create efficient implantable biomedical devices, including cardiovascular stents. The proper statistical approaches along with results from clinical studies including model-based risk probability prediction from genetic and physiological variables are integral for monitoring and treatment of CVD risk.
Conclusions: To overcome the current obstacles in cardiac repair and regeneration and achieve successful therapeutic applications, future interdisciplinary collaborative work is essential. Novel cardiovascular devices and their targeted treatments will accomplish enhanced health care delivery and improved therapeutic efficacy against CVD. As the review articles contain comprehensive sources for state-of-the-art evidence for clinicians, these high-quality reviews will serve as a first outline of the updated progress on cardiovascular devices before undertaking clinical studies.
背景:心血管疾病(cvd)是全球死亡的主要原因,美国几乎一半的成年人至少患有一种心脏病。本文综述了心血管疾病的先进技术、遗传变量和用于不依赖器官的心血管修复系统的生物材料。目的:各种植入式和可穿戴设备,包括配备生物传感器的心血管支架和生物相容性心脏贴片,已经被开发和评估。这些策略的结合将为心血管疾病的高级临床管理带来光明的前景。方法:本研究采用谷歌Scholar、PubMed、Web of Science等广泛使用的学术检索系统。最近的进展在诊断和治疗方法对抗心血管疾病,如内容所述,广泛审查。创新的生物工程、基因传递、细胞生物学和基于人工智能的技术将不断革新心血管修复和再生的生物医学设备。本文采用的新颖、平衡、现代、基于查询的方法定义了更新的文献综述可以有效地为临床治疗心血管疾病的心血管装置提供循证、全面适用性的研究的程度。结果:先进的技术以及基于人工智能的远程医疗对于创造高效的植入式生物医学设备至关重要,包括心血管支架。适当的统计方法以及临床研究的结果,包括基于遗传和生理变量的基于模型的风险概率预测,对于监测和治疗心血管疾病风险是不可或缺的。结论:为了克服目前心脏修复和再生的障碍,实现成功的治疗应用,未来的跨学科合作是必不可少的。新型心血管设备及其靶向治疗将增强心血管疾病的医疗服务,提高心血管疾病的治疗效果。由于综述文章为临床医生提供了最先进证据的全面来源,这些高质量的综述将在进行临床研究之前作为心血管装置最新进展的第一个大纲。